Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1998 Aug;36(8):2375–2376. doi: 10.1128/jcm.36.8.2375-2376.1998

Human Infection with Hymenolepis diminuta: Case Report from Spain

Daniel Tena 1, Montserrat Pérez Simón 1, Carmen Gimeno 1, María Teresa Pérez Pomata 1,*, Soledad Illescas 1,, Izaskun Amondarain 1, Alejandro González 1, Jesús Domínguez 1, Julia Bisquert 1
PMCID: PMC105055  PMID: 9666029

Abstract

We report a case of Hymenolepis diminuta infection in a human. The patient was a 5-year-old girl referred to us through the onset of a cyanotic attack. Treatment with a single dose (10 mg/kg of body weight) of praziquantel was ineffective, but the parasite was eradicated after three treatment cycles with the same drug at dosages of 25 mg/kg/day for 5 days.


Hymenolepis diminuta is a tapeworm that occurs throughout the world. Its principal definitive hosts are rodents. Nevertheless, in rare instances, it can infect humans, when by accidental ingestion of infected arthropods, cysticercoids find their way to the small intestine (15). We report one case of H. diminuta infection in a child from Guadalajara, Spain.

A 5-year-old girl, who lived near a grain silo infested with rats, was referred to our Pediatric Unit because, during an episode of apnea induced by crying, she became cyanotic, lost consciousness, and experienced stiffness of the limbs followed by drowsiness and hypotony. The little patient occasionally complained of abdominal pain and anal pruritus. She also endured enuresis and restless nights. Subsequent physical examination, complemented by electroencephalography and skull and chest roentgenograms, was normal. No abnormal readings were found in blood and urine analysis. A Graham test verified absence of Enterobius vermicularis eggs. The parasitological examination of concentrated stools (10) revealed spherical, 70-μm-diameter, thick-shelled eggs that contained six central hooklets but no polar filaments (Fig. 1); they were identified as H. diminuta eggs. Oral niclosamide (1 g/day for 15 days) was prescribed. Neurological signs were subsequently labeled as cyanotic attacks.

FIG. 1.

FIG. 1

H. diminuta egg at ×40 magnification.

A second parasitologic examination carried out 30 days after diagnosis demonstrated the presence of H. diminuta eggs and Giardia lamblia cysts. The mother and the only brother were found to evacuate G. lamblia cysts as well. During the follow-up visit, the parents admitted that the niclosamide treatment had not been performed as prescribed. At that time, abdominal pain was still present, whereas neurological signs had not reappeared. Consequently, the patient was put on oral metronidazole (375 mg/day) for 7 days, supplemented by a single dose of praziquantel (10 mg/kg of body weight).

One month after completion of the treatment, the child was asymptomatic, but G. lamblia cysts and H. diminuta eggs were again found in feces. In view of the circumstances, she was given a single dose of tinidazole (1 g) followed up by three cycles of 25 mg of praziquantel per kg/day, with each cycle lasting 5 days. Parasitological examinations carried out 1, 3, and 6 months after the completion of the third treatment cycle were all negative.

Rats and other rodents are usually H. diminuta’s definitive targets and natural reservoir. Coprophilic arthropods act as obligatory intermediate hosts (28). When the infected arthropod is eaten by the definitive host, cysticercoids present in its body cavity develop into an adult worm, and its eggs are eliminated in feces (2). Complementing other authors’ findings (8, 16), we have pinpointed the likely source of infection in our patient to the proximity of a grain silo infested with rats to the patient’s house.

H. diminuta human infection is rather uncommon. Surveys of different populations have reported parasitization rates ranging between 0.001 and 5.5% (5, 1721, 23, 27), and descriptions of isolated cases are rare indeed (6, 11, 25, 29). In our country, Spain, seven H. diminuta human infections have been reported so far, and all of them concerned children (4, 12, 30, 31). According to the data obtained from a Medline search, in the United States, 48 cases have been reported since 1965 (7, 8, 13, 14, 16, 22).

Although H. diminuta infection is often asymptomatic (2, 3), abdominal pain (2, 3, 8), irritability (2, 30, 31), and pruritus (2) have been associated with this condition. H. diminuta infection may cause eosinophilia (3), a finding that was not detected in our patient. The relationship between abdominal discomfort and H. diminuta infection was difficult to establish, because that symptom disappeared way ahead of the cestode’s eradication. The conjectural presence of G. lamblia that may have gone undetected during the first parasitological examination is also a well-known cause of abdominal pain in infected individuals (9). Irritability might have given rise to the cyanotic attack.

Praziquantel is the drug of choice for treatment of H. diminuta infection (2), but niclosamide is also effective (13, 14). Our patient was initially prescribed niclosamide, but the treatment regimen was not respected. A single dose of praziquantel (10 mg/kg) failed to annihilate the tapeworm. Currently used therapeutic handbooks do not discuss H. diminuta treatment (1, 24), perhaps because of its low prevalence. We believe that in the present case, a single 25-mg/kg praziquantel dose, as recommended for Hymenolepis nana infection (1, 24), followed by a new parasitological examination of stools should have been the next and most appropriate management step; instead, the pediatrician decided to prescribe a more prolonged treatment to ensure eradication. Given the lack of data about praziquantel treatment (1, 24, 26), we suggest that every case of H. diminuta infection be reported, especially data regarding treatment protocols and parasitological responses.

Acknowledgments

We thank J. Keller for reviewing the English version of the manuscript.

REFERENCES

  • 1.Abramowicz M, Rizack M A, Hirsch J, Kenney J D, Rowland L P, Schaffner F, Steigbigel N H, Adeloff M D, Beaver W T, Gelenberg A J, Goodman L S, Hansten P D, Levy G, Mandell G L, Roden D M, Tinnkerm J H, Hilman C, Goodstein D. Medicamentos contra las infecciones parasitarias. Med Lett Drug Ther. 1995;17:113–124. [Google Scholar]
  • 2.Acha P N, Szyfres B. Hymenolepiasis. In: Acha P N, Szyfres B, editors. Zoonosis y enfermedades transmisibles comunes al hombre y a los animales. 2nd ed. Washington, D.C: Servicio Editorial de la Organización Panamericana de la Salud; 1984. pp. 754–758. [Google Scholar]
  • 3.Baily G C. Intestinal cestodes. In: Cook G C, editor. Manson’s tropical diseases. 10th ed. London, England: W. B. Saunders Company, Ltd.; 1996. pp. 1477–1485. [Google Scholar]
  • 4.Buen S. Sobre una tenia nueva en España. Bol Soc Esp Biol. 1914;1:83. [Google Scholar]
  • 5.Chung W C, Fan P C, Chiu H M. Survey of helminthic infections and treatment of Taenia sp infection among the aborigines in Chienshih District, Hsin-Chu County, northern Taiwan. Chung-Hua Min Kuo Wei Sheng Wu Chi Mein I Hsuech Tsa Chih. 1985;18:96–103. [PubMed] [Google Scholar]
  • 6.Cohen I P. A case report of Hymenolepis diminuta infection in a child in St. James Parish, Jamaica. J La State Med Soc. 1989;141:143. [PubMed] [Google Scholar]
  • 7.Cohen R, Mackey K. Hymenolepis diminuta unresponsive to quinacrine. West J Med. 1977;127:340. [PMC free article] [PubMed] [Google Scholar]
  • 8.Edelman M H, Springarn C L, Nauenberg W G, Gregory C. Hymenolepis diminuta (rat tapeworm) infection in man. Am J Med. 1965;38:951. doi: 10.1016/0002-9343(65)90015-x. [DOI] [PubMed] [Google Scholar]
  • 9.Farthing M J, Cevallos A M, Kely P. Intestinal protozoa. In: Cook G C, editor. Manson’s tropical diseases. 10th ed. London, England: W. B. Saunders Company, Ltd.; 1996. pp. 1255–1289. [Google Scholar]
  • 10.Galdames M, Zuloaga M, Jarpa A. Diagnóstico coproparasitario mediante los métodos de Teleman modificado y Burrows. Bol Chil Parasitol. 1984;39:10–12. [PubMed] [Google Scholar]
  • 11.González N, Molinas M A, León J. Casos humanos de Hymenolepis diminuta. Rev Parasitol Microbiol II. 1967;1:58–60. [Google Scholar]
  • 12.Guevara D, Domínguez J. Un nuevo caso en España de parasitismo humano por Hymenolepis diminuta. Rev Iber Parasitol. 1955;1955:459. [Google Scholar]
  • 13.Hamrick H J, Bowdre J H, Church S M. Rat tapeworm (Hymenolepis diminuta) infection in a child. Pediatr Infect Dis J. 1990;9:216–219. doi: 10.1097/00006454-199003000-00016. [DOI] [PubMed] [Google Scholar]
  • 14.Jones W E. Niclosamide as a treatment for Hymenolepis diminuta and Dipylidium caninum infection in man. Am J Trop Med Hyg. 1979;28:300–302. doi: 10.4269/ajtmh.1979.28.300. [DOI] [PubMed] [Google Scholar]
  • 15.King C H. Cestodes (tapeworms) In: Mandell G L, Bennet J E, Dolin R, editors. Principles and practice of infectious diseases. New York, N.Y: Churchill Livingstone; 1995. pp. 2544–2553. [Google Scholar]
  • 16.Levi M H, Raucher B G, Teicher E, Sheehan D J, McKitrick J C. Hymenolepis diminuta: one of the three enteric pathogens isolated from a child. Diagn Microbiol Infect Dis. 1987;7:255–259. doi: 10.1016/0732-8893(87)90140-4. [DOI] [PubMed] [Google Scholar]
  • 17.Lo C T, Ayele Y, Birrie H. Helminth and snail survey in Harerge region of Ethiopia with special reference to schistosomiasis. Ethiop Med J. 1989;27:73–83. [PubMed] [Google Scholar]
  • 18.McMillan B, Kelly A, Walker J C. Prevalence of Hymenolepis diminuta infection in man in the New Guinea Highlands. Trop Geogr Med. 1971;23:390–392. [PubMed] [Google Scholar]
  • 19.Mercado R, Arias B. Infecciones por Taenia sp y otros cestodos intestinales en pacientes de consultorios y hospitales públicos del Sector Norte de Santiago de Chile (1985–1995) Bol Chil Parasitol. 1995;50:80–83. [PubMed] [Google Scholar]
  • 20.Náquira C, Delgado E, Tantaleán M, Náquira F, Elliot A. Prevalencia de enteroparásitos en escolares de los distritos de San Juan y Magdalena. Rev Peru Med Trop. 1973;2:37–40. [Google Scholar]
  • 21.Panpiglione S, Visconti S, Pezzino G. Human intestinal parasites in Subsaharan Africa II. Sao Tomé and Principe. Parassitologia. 1987;29:15–25. [PubMed] [Google Scholar]
  • 22.Ratliff C R, Donalson L. A human case of Hymenolepis diminuta. J Parasitol. 1965;51:808. [PubMed] [Google Scholar]
  • 23.Reyes H, Inzunza E, Doren G. Frecuencia de infección humana por Hymenolepis diminuta en Santiago de Chile (1957–1971) Bol Chil Parasitol. 1972;27:28–33. [PubMed] [Google Scholar]
  • 24.Sandford J P, Gilbert D N, Sande M A. Antiparasitic agents. In: Sandford J P, editor. Guide to antimicrobial therapy. Dallas, Tex: Antimicrobial Therapy Inc.; 1996. pp. 83–95. [Google Scholar]
  • 25.Sane S Y, Irani S, Jain N, Shah K N. Hymenolepis diminuta: a rare zoonotic infection report of a case. Indian J Pediatr. 1984;51:743–745. doi: 10.1007/BF02776395. [DOI] [PubMed] [Google Scholar]
  • 26.Silva N, Guyyat H, Bondy D. Anthelmintics: a comparative review of their clinical pharmacology. Drugs. 1997;53:769–788. doi: 10.2165/00003495-199753050-00004. [DOI] [PubMed] [Google Scholar]
  • 27.Stafford E E, Sudomo M, Marsi S, Brown R J. Human parasitoses in Bali, Indonesia. Southeast Asian J Trop Med Public Health. 1980;11:319–323. [PubMed] [Google Scholar]
  • 28.Tantaleán Z, Cáceres I. Hospedadores intermediarios de Hymenolepis diminuta en Lima (Perú) Rev Peru Med Trop. 1972;22:27. [Google Scholar]
  • 29.Tesjaroen S, Chareonlarp K, Yoolek A, Mai-iam W, Lertlaituan P. Fifth and sixth discoveries of Hymenolepis diminuta infections in Thai people. J Med Assoc Thail. 1987;70:49–50. [PubMed] [Google Scholar]
  • 30.Vasallo M, González F. Un nuevo hallazgo de parasitación humana en España por Hymenolepis diminuta. Rev Clin Esp. 1979;153:321–322. [PubMed] [Google Scholar]
  • 31.Velasco A C, Mateos M L, Gutiérrez A. Parasitación humana por Hymenolepis diminuta y revisión de la literatura. Rev Diagn Biol. 1980;29:372–375. [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES